Table 1.
Phytochemical constituents of Cannabis sativa with pharmacological activities.
Name of phytochemicals isolated from Cannabis sativa | Source organ or plant part | Bioactivity as reported by the researchers or experimentally analysed | Key points of the experimental approach | References |
---|---|---|---|---|
Delta-9-tetrahydrocannabinol and cannabidiol, cannabinol, cannabigerol, cannabigerolic acid and cannabichromene | Flower | Psychoactive properties* | Phytochemical screening of marketed medical marihuana samples was carried out. | Mudge et al., 2016 |
tetrahydrocannabinol, cannabidiol, cannabigerol, cannabichromene, tetrahydrocannabivarin | Flowers and inflorescence leaves | Psychoactive properties* | Chemical profiling of cannabinoids demonstrated organ- and location-specific regulation of accumulation | Bernstein et al., 2019 |
Essential oil component rich in terpenes and cannabinoid | Dried flower | Antioxidant properties and anti acetylcholinesterase activities** | GC–FID and GC–MS analyses revealed the chemical composition and indicated a possible synergistic attribution of terpenes and phytocannabinoids | Smeriglio et al., 2020 |
(±)-6,7-trans-epoxycannabigerolic acid, (±)-6,7-cis-epoxycannabigerolic acid, (±)-6,7-cis-epoxycannabigerol, (±)-6,7-trans-epoxycannabigerol, 5′-methyl-4-pentylbiphenyl-2,2′,6-triol, and 7-methoxycannabispirone, cannabigerolic acid, 5′-methoxycannabigerolic acid, cannabispirone, β-cannabispiranol, dehydrocannabifuran, cannflavin B and cannabigerol | Whole buds of mature female plants | Antimicrobial and antileishmanial activities** | Identification, isolation and characterization of novel Cannabis constituents and their pharmacological activities were determined. | Radwan et al., 2008a |
Cannabichromanones A, B, C, D | Whole buds of mature female plants | Analgesic, antidepressant, anticancer, and psychoactive properties* | ORD and CD were used to determine the configuration of cannabichromanone derivatives. | Ahmed et al., 2008a |
Δ9‐tetrahydrocannabiorcol, cannabidivarin, cannabicitran, Δ9‐tetrahydrocannabivarin, cannabicyclol, cannabidiol, cannabichromene, Δ9‐tetrahydrocannabinol, cannabigerol, cannabinol, dihydrocannabinol, cannabielsoin, 6a, 7, 10a‐trihydroxytetrahydro cannabinol, 9, 10‐epoxycannabitriol, 10‐O‐ethylcannabitriol, and 7, 8‐dehydro‐10‐O‐ethylcannabitriol, kaempferol 3‐O‐sophoroside and quercetin 3‐O‐sophoroside |
Pollen grains | Antioxidant and anti-inflammatory activities* | High‐field 2D-NMR experiments, application of GC‐FID and GC‐MS analyses revealed the presence of cannabinoids and glycosides | Ross et al., 2005 |
β-ocimene, α-terpinolene, α- and ß-pinene, ß-myrcene, sesquiterpenes (trans-caryophyllene and α-humulene), tetrahydrocannabinol, cannabidiol, cannabidiolic acid, cannabigerolic acid, cannabidivarin | Inflorescences | Dietary supplement* | HPLC-high-resolution mass spectrometry, LC-MS/MS, HS-SPME GC–MS, and GC-FID were performed to illustrate the complete chemical profile. | Pavlovic et al., 2019 |
Orientin, vitexin, isovitexin, quercetin, luteolin, kaempferol, apigenin | Flowers, seedlings and fruits. | Carcinogens detoxification, enzyme activation** | Inhibited prostaglandin E2 production in rheumatoid synovial cells | Schewe et al., 2002, Moon et al., 2006 |
Cannflavins A, B, and C | Sprouts, flower bud | Antimicrobial and antileishmanial activity** | Therapeutic potential revealed along with antioxidant efficacy | Radwan et al., 2008a, Radwan et al., 2008b |
Cannabis in-B, C, D, G, grossamide | Fruit, root | Chemical protection against pathogenic attack* | Isolation and characterization of polyphenols | Calvi et al., 2018 |
Cannabispirone, iso-cannabispirone, iso-cannabispiradienone, cannabispirenone-B, β-cannabispiranol, α -cannabispiranol, 5,7-dihydroxyindan-1-spiro-cyclohexane, 7-hydroxy-5-methoxyindan-1-spirociclohexane | Resin, flower heads, stem, and leaves | Antioxidant activities* | Isolation, biosynthesis and bioactivity of stilbenoids | Calvi et al., 2018 |
Tetrahydrocannabinol, tetrahydrocannabinolic acid synthase, cannabinol | Leaves | Psychoactive agent* | The oldest documentation of pharmacological application revealed | Russo et al., 2008 |
α-zone and β-zone | Leaves | Psychoactive properties* | The OPLC method was applied to separate neutral and acidic cannabinoids | Oroszlán et al., 1987 |
Cannabidiolic acid, cannabidiol, cannabidiol monomethyl ether, cannabidiol-C4, cannabidivarinic acid, cannabidivarin, cannabidiorcol | Leaves/plant | Psychotropic, analgesic, anti-inflammatory activities* | The therapeutic potential and occurrence of different cannabinoids were discussed. | Asati et al., 2017 |
(E)‐caryophyllene, cannabidiol, cannabidiolic acid, kaempferol, and apigenin | Leaves, male and female inflorescences | CB2 agonists with nutraceutical and pharmaceutical properties* | GC/MS, NMR, and LC‐DAD‐MS techniques revealed essential oil composition | Nagy et al., 2019 |
Δ9-tetrahydrocannabinol and cannabidiol (resorcinol and 2-p-mentha-1,8-dien-4-yl-5-pentyl) | Leaves, stems, and seeds | Antimicrobial activities (detected by agar well diffusion method against four pathogenic bacteria strains) ** | Mineral analysis, GC–MS, and antimicrobial assay were conducted to determine the bioactivity of cannabinoids. | Isahq et al., 2015 |
Δ9-trans-tetrahydrocannabivarin, Δ9-trans-tetrahydrocannabinol, sterols (campesterol, stigmasterol, p-sitosterol), amino acid (L-proline) | Young stem | Psychotomimetic activity* | Phytochemical screening was performed via GLC-MS. | Mole and Turner, 1974 |
rac-6′,7′-dihydro,6′,7′-dihydroxycannabigerol | Aerial parts | Antibacterial activity** | Polar cannabinoid isolated and characterized by spectrometric analysis | Appendino et al., 2008 |
Denbinobin |
Whole plant |
Antiproliferative activity** |
Causes mitochondrial dysfunction, protein kinase B (Akt) and NF-kB pathway inactivation, Bcl-2- associated death promoter and caspase 3 activation and releases apoptosis-inducing factor (AIF) in human lung adenocarcinoma, Jurkat and other human leukemia cell lines |
Kuo et al., 2008, Sánchez-Duffhues et al., 2009 |
Tetrahydrocannabinol, cannabidiol, cannabinol, cannabichromene, cannabigerol, α- pinene, 1,8-cineole, pulegone, d- limonene, β – caryophyllene, apigenin, β- sitosterol, quercetin |
Plant |
Antidepressant, sedative, anti-inflammatory, antioxidant analgesic activities* | Dopamine antagonists and their role against Cannabis dependency were noted. |
Oladimeji and Valan, 2020 |
Cannabidiol |
Plant |
Anticancer activity** |
The antiproliferative activity of cannabidiol on different cervical cancer cell lines was tested | Lukhele and Motadi, 2016 |
β-fenchyl Δ9-tetrahydrocannabinolate, epi-bornyl Δ9-tetrahydrocannabinolate, α-terpenyl Δ9-tetrahydrocannabinolate, 4-terpenyl Δ9-tetrahydrocannabinolate, α-cadinyl Δ9-tetrahydrocannabinolate, γ-eudesmyl Δ9-tetrahydrocannabinolate, γ-eudesmyl cannabigerolate, 4-terpenyl cannabinolate, bornyl Δ9-tetrahydrocannabinolate (9), α-fenchyl Δ9-tetrahydrocannabinolate, α-cadinyl cannabigerolate, Δ9-tetrahydrocannabinol, Δ9-tetrahydrocannabinolic acid A, cannabinolic acid A, and cannabigerolic acid |
Plant |
Moderate antimicrobial activity** |
Extensive spectroscopic analyses revealed their structural identity |
Ahmed et al., 2008b |
Δ9-tetrahydrocannabinol, Δ9-tetrahydrocannabinolic acid |
Plant (water extracts) |
Psychoactive herbal remedies* |
Diffusion-edited 1H NMR (1D DOSY) and 1H NMR provided semiquantitative data on phyto-cannabinoids |
Politi et al., 2008 |
Caffeoyltyramine, cannabisin A, B, C, ω-6 linoleic acid |
Seed, sprouts |
Cellular antioxidant activity, anti-mutagenic** | Spectrophotometric analysis of phytochemicals and antioxidant assays revealed its potency as a functional food | Frassinetti et al., 2018 |
Cannabisin I (1), together with seven known lignanamides, cannabisins A, B, C, F, M, 3,3′-demethylgrossamide, grossamide, N-trans-caffeoyltyramine and N-trans-caffeoyloctopamine |
Hempseed cakes |
Arginase inhibitory property and antioxidant capacity** |
NMR spectroscopy and mass spectrometry data determined the structure of lignanamides and phenylpropanoid amides |
Bourjot et al., 2017 |
Linoleic, α-linolenic and oleic acid, β-sitosterol, campesterol, phytol, cycloartenol, γ-tocopherol |
Seed oil |
Antioxidant activity* |
A qualitative and quantitative characterization of the unsaponifiable fraction was performed. |
Paz et al., 2014 |
Hemp protein isolate (HPI) containing edestin (hexameric legumin) |
Seed |
Nutraceutical value** |
Emulsifying activity index, emulsion stability index, water holding capacity, and fat adsorption capacity indicate the role of HPI as a functional food |
Tang et al., 2006 |
Δ9‐tetrahydrocannabinol and other neutral cannabinoids |
Seed |
Psychoactive properties and other pharmacological activities* | Simple, reproducible, and accurate, the HPTLC method was standardized for the quantification of Δ9‐THC | Fischedick et al., 2009 |
Linolenic acid, oleic acid, sitosterol, campesterol, phytol, cycloartenol and tocopherol |
Seed |
Nutraceutical value** |
Phytochemical characterization of the unsaponifiable fraction determined via analytical studies |
Paz et al., 2014 |
3,3′-demethyl-grossamide, cannabisin-M 111, cannabisin- N, (2,3-trans)-3-(3-hydroxy-5-methoxyphenyl)- N-(4-hydroxyphenethyl)-7-{(E)-3-[(4-hydroxyphenethyl) amino]-3-oxoprop-1-enyl}-2,3-dihydrobenzo [b] [1,4] dioxine-2-carboxamide, cannabisin-O, and 3,3′-demethyl-heliotropamide |
Seed |
Antioxidant and acetylcholinesterase inhibitory activities** |
Phytochemical characterization and pharmacological studies revealed the presence of phenolic amides and lignanamides. |
Yan et al., 2015 |
Quercetin, gallic acid, p Coumaric acid, m-coumaric acid, caffeic acid, cinnamic acid, ferulic acid, benzoic acid, and kaempferol |
Seed |
Antioxidant and chemopreventive activities* | High-throughput phytochemical characterization of noncannabinoid compounds via HPLC screening |
Ahmad et al., 2018 |
Phenylpropionamides |
Seed |
Ameliorated LPS stimulated memory dysfunction and neuroinflammation in mice** | Reversal of hippocampal neuronal damage supports the nutraceutical potential and the neuroprotective perspective of hemp seed. |
Zhou et al., 2018a |
Cannabisin A, B, F, G, M, 3,3′-demethyl-grossamide,N-trans-coumaroyloctopamine, N-trans-coumaroyltyramine, N-trans-feryroyltyramine, N-trans-caffeoyltyramine, (S)-N-(2-(4-hydroxyphenyl)-2-methoxyethyl)cinnamamide,4-[(E)-p-coumaroylamino]butan-1-ol, trans-ferulic acid-4-O-β-D-glucopyranoside, adenosine, p-hydroxybenzaldehyde, and 4-hydroxy-3-acid |
Seed |
Anti-neuroinflammatory activity** |
Many of these compounds inhibited TNF-α release from LPS-induced BV2 microglia cells, which is an important therapeutic approach for neurodegenerative diseases. |
Zhou et al., 2018b |
Polyunsaturated fatty acids, protein (ß-conglycinin and vicilin) | Seed | Health-promoting property* | Cannabinoid profiling performed using an untargeted metabolomics approach | Pavlovic et al., 2019 |
Fatty acids (palmitic, stearic, oleic, linoleic, γ-linolenic and α-linolenic acid), tocopherols, carotenoids (lutein, β-carotene, zeaxanthin), protocatechuic acid, p-hydroxybenzoic acid, cinnamic acid, trans-caffeoyltyramine, cannabisin A |
Seed |
Antioxidant activity (detected by ABTS and FRAP assays) ** |
The nutritional value, phytochemical composition, and antioxidant properties of seven hemp cultivars were detected. |
Irakli et al., 2019 |
Monoterpene (limonene, β-myrcene, and α-pinene), sesquiterpene (caryophyllene and humulene) |
Seed |
Various pharmacological activities* | The terpene metabolomics study (based on GC–MS) helped in phytochemical screening | Mudge et al., 2019 |
Hemp protein hydrolysates (HPH20A and HPH60A + 15AF) |
Seed |
Anti-neuroinflammatory activities** |
Down-regulated transcriptional levels of TNF-α, IL-1β, and IL-6 mRNA in LPS-stimulated BV-2 microglial cells; up-regulated expression of the IL-10 cytokine gene |
Rodriguez-Martin et al., 2019 |
(−)-trans-Δ9-tetrahydrocannabiphorol (Δ9-THCP) | Seed | In vivo cannabimimetic activity** | As a potent CB1 agonist, it induced catalepsy, analgesia, and hypomotility; decreased rectal temperature |
Citti et al., 2019 |
Δ9-tetrahydrocannabinolic acid (A) and its neutral derivative trans-Δ9-tetrahydrocannabinol-C5, Cis and trans-Δ9-tetrahydrocannabinol-C7 isomers |
Seed |
Psychoactive properties* |
A phytochemical investigation by mass spectrometry revealed the presence of homologues of trimethylsilyl (TMS) derivatives | Basas-Jaumandreu and De Las Heras, 2020 |
Cannabidiol, cannabidiolic acid, cannabinol, tetrahydrocannabinol, tetrahydrocannabinolic acid | Cannabis medicinal extracts (oil and alcohol-based CMEs) |
Psychoactive properties* |
LC–MS/MS using an untargeted metabolomics approach revealed the effect of decarboxylated cannabinoids on pharmacological activity |
Citti et al., 2018 |
*Activities are reported based on previous research
**Activities are experimentally determined by the corresponding researchers